ArticleFrontiers in oncology2024

Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs.

Daiki Ikarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.